NeuroOne Medical Technologies (NMTC)

• Market cap: $37.1M
• 1 day: -0.79%
• 5 days: -6.19%
• 1 month: -7.73%
• 3 months: -18.03%
• 6 months: -22.98%
• Year to date: -14.15%
• 1 year: 70.08%
• 5 years: -89.89%
• 10 years: -89.89%
• Sector: Healthcare
• Industry: Medical Devices

About: NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Employees: 18